Blast Phase Chronic Myeloid Leukemia

• CLINICAL_TRIALS trial_result · 2016-08-18
  Clinical Trial Update: Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation [Phase 2]

  Phase 2 trial update evaluating immunotherapy for relapse after allogeneic transplantation in acute myeloid leukemia, acute lymphoblastic le…

• CLINICAL_TRIALS withdrawal · 2015-10-30
  Clinical Trial Update: Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia [Phase 2]

  A Phase 2 study evaluating Nilotinib with combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic …

• CLINICAL_TRIALS trial_result · 2015-04-15
  Clinical Trial Update: Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase [Phase 1]

  This update summarizes a Phase 1 study of tipifarnib and bortezomib in patients with acute leukemia and blast-phase chronic myeloid leukemia…

• CLINICAL_TRIALS trial_result · 2013-01-24
  Clinical Trial Update: STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia [Phase 1, Phase 2]

  A Phase 1/2 clinical trial evaluating the combination of STI571 (imatinib) with cytarabine in patients with chronic myeloid leukemia, includ…

• CLINICAL_TRIALS trial_result · 2013-01-23
  Clinical Trial Update: Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia [Phase 2]

  A Phase 2 study of bevacizumab, idarubicin, and cytarabine in patients with blast phase chronic myeloid leukemia (including BCR-ABL1-positiv…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.